Home / Inspections / 1099616

FDA Inspection 1099616 — Glaxo Operations UK Limited

Glaxo Operations UK Limited — FEI 3003262904

The FDA completed an inspection of Glaxo Operations UK Limited on January 25, 2019 in Ware. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ware (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1267917 (VAI Fri Dec 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102175 (VAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935343 (NAI Fri Jul 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 898406 (NAI Fri Sep 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 827578 (VAI Thu Apr 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources